Form D · Pharmaceuticals

Scilex Pharmaceuticals Inc.

Malvern, PA · CIK 0001603542

Offering snapshot reported May 17, 2016 · SEC filing

Reported sold
$480K
Offering amount: $480K
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 4, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 17, 2016Initial$479,930No comparison9SEC filing
Mar 31, 2015Initial$2,025,274No comparison3SEC filing
Aug 7, 2014InitialYet to sellNo comparison0SEC filing
Aug 4, 2014Amendment$5,001,700$0vs Mar 26, 201412SEC filing
Mar 26, 2014Initial$5,001,700No comparison12SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-263323
Mid Atlantic Medical Associates LLC will receive options to purchase up to 3,000 shares of common stock

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Mid Atlantic Medical Association, LLCNone

Source: Form D, filed May 17, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard Cohen Executive
Eric Floyd Director
Anthony Mack Director, Executive
William Pedranti Director, Executive
Jerrold Sendrow Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
301 Lindenwood Dr. Suite 300
Malvern, PA, 19355